Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8782-8791

  Lieber, André ^a   He, Cheng Yi ^a   Polyak, Stephen J ^a   Gretch, David R ^a   Barr, Darlene ^a   Kay, Mark A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; VIRUS RNA;

ADENOVIRUS; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; ENZYME ACTIVITY; GENE EXPRESSION; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMAN; HUMAN CELL; LIVER CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS HEPATITIS;

EID: 0029970824     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8782-8791.1996     Document Type: Article

References (36)

1. Alt, M., R. Renz, P. H. Hofsschneider, G. Paumgartner, and W. H. Caselmann. 1995. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 22:707-717.
2. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, and P. Y. Hu. 1992. The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327:1899-1905.
3. Brown, A. A., H. Zhang, L. H. Ping, and S. M. Lemon, 1992. Secondary analysis of the 5′ noncoding region of hepatitis C virus. Nucleic Acids Res. 20:5041-5045.
4. Bukh, J., R. H. Purcell, and R. H. Miller. 1992. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA 89:4942-4946.
5. Choo, Q.-L., K. H. Richman, J. H. Man, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, A. Medina-Selby, P. J. Barr, A. J. Weiner, D. W. Bradley, G. Kuo, and M. Houghton. 1991. Genetic organization and diversity of hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
6. Davis, G. L. 1994. Interferon treatment of chronic hepatitis C. Am. J. Med. 96:41S-46S.
7. Davis, G. L. Personal communication.
8. Durnham, D. M., and R. Palmiter. 1983. A practical approach for quantitating specific mRNAs by solution hybridization. Anal. Biochem. 131:385-393.
9. Farci, P., and R. H. Purcell. 1993. Natural history and animal models, p. 241-267. In A. J. Zuckerman and A. C. Thomas (ed.). Viral hepatitis: scientific basis and clinical management. Edinburgh.
10. Fong, T. L., M. Shindo, S. M. Fienstone, J. H. Hoofnagle, and A. M. DiBiscegli. 1991. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J. Clin. Invest. 88:1058-1060.
11. Grakoui, A., C. Wychowski, C. Lin, S. M. Feinstone, and C. M. Rice. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1385-1395.
12. Gretch, D., C. E. Bacchi, L. Corey, C. dela-Rosa, R. R. Lesniewski, K. Kowdley, A. Gown, I. Frank, J. D. Perkins, and R. L. J. Carithers. 1995. Persistent hepatitis C virus infection after liver transplantation: clinical and virologic features. Hepatology 22:1-9.
13. Han, J. H., V. Shymala, K. H. Richman, M. J. Brauer, B. Irvine, M. S. Urdea, P. Tekamp-Olson, G. Kuo, Q. L. Choo, and M. Houghton. 1991 Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc. Natl. Acad. Sci. USA 88:1711-1715.
14. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q. J. Choo. 1991. Molecular biology of the hepatitis C viruses: implication for diagnosis, development and control of viral disease. Hepatology 14:381-388.
15. Kay, M. A., F. Graham, F. Leland, and S. L. Woo. 1995. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815-819.
16. Koziel, M. J., D. Dudley, J. T. Wong, J. Dienstag, M. Houghton, R. Raslton, and B. D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in person with chronic hepatitis, J. Immunol. 149:3339-3343.
17. Lanford, R. E., D. Chavez, F. V. Chisari, and C. Sureau. 1995. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69:8079-8083.
18. Lemm, J. A., M. Heise, and C. M. Rice. Unpublished data.
19. Lieber, A., and M. A. Kay. 1996. Adenovirus-mediated expression of rihozymes in mice. J. Virol. 70:3153-3158.
20. Lieber, A., V. Sandig, W. Sommer. S. Bahring, and M. Strauss. 1993. Stable high-level gene expression in mammalian cells by T7 phage RNA polymerase. Methods Enzymol. 217:47-66.
21. Lieber, A., V. Sandig, and M. Strauss. 1993. A mutant T7 phage promoter is specifically transcribed by T7-RNA polymerase in mammalian cells. Eur. J. Biochem. 217:387-394.
22. Lieber, A., and M. Strauss. 1995. Selection of efficient cleavage sites in target RNAs by using a ribozyme library. Mol. Cell. Biol. 15:540-551.
23. Lieber, A., M. J. T. F. D. Vrancken Peeters, and M. A. Kay. 1995. Adenovirus-mediated transfer of the amphotropic retrovirus receptor cDNA increases retroviral transduction in cultured cells. Hum. Gene Ther. 6:5-11.
24. Martinot-Peignoux, M., P. Marcellin, M. Pouteau, C. Castelnau, N. Boyer, M. Poliquin, C. Degott, I. Descombes, V. Le-Breton, V. Milotova, et al. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22: 1050-1056.
25. Negro, F., D. Pacchioni, Y. Shimizu, R. H. Miller, G. Bussolati, R. H. Purcell, and F. Bonino. 1992. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc. Natl. Acad. Sci. USA 89:2247-2251.
26. Nouri Aria, K. T., R. Sallie, D. Sangar. G. J. M. Alexander, H. Smith, J. Byrne, B. Portmann, A. L. W. F. Eddleston, and R. Williams. 1993. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J. Clin. Invest. 91:2226-2234.
27. Poeschia, E., and F. Wong-Staal. 1994. Antiviral and anticancer ribozymes. Curr. Opin. Oncol. 6:601-606.
28. Shimizu, Y. K., R. H. Purcell, and H. Yoshikura. 1993. Correlation between the infectivity of hepatitis C virus in vivo and infectivity in vitro. Proc. Natl. Acad. Sci. USA 90:6037-6041.
29. Simmonds, P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
30. Sullivan, S. M. 1994. Development of ribozymes for gene therapy. J. Invest. Dermatol. 103:85S-89S.
31. Tsukiyama-Kohara, K., N. Iizula, M. Kohara, and A. Nomoto. 1992. Internal ribosome entry site within the HCV RNA. J. Virol. 66:1476-1483.
32. Vrancken Peeters, M. J. T. F. D., A. Lieber, J. Perkins, and M. A. Kay. 1996. A method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. BioTechniques 20:278-285.
33. Wakita, T., and J. R. Wands. 1994. Specific inhibition of hepatitis C virus expression by antisense oligonucleolides: in vitro model for selection of target sequence. J. Biol. Chem. 13:14205-14210.
34. Walker, C. M. 1996. Cytotoxic T-lymphocyte responses to the hepatitis C virus in humans and chimpanzees. Semin. Virol. 7:13-21.
35. Wang, J.-T., J.-C. Sheu, J.-T. Lin, T.-H. Wang, and D. S. Chen. 1992. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J. Infect. Dis. 166:1167-1169.
36. Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755-2759.